Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: PD-L1 Strong Metastatic Non-Small Cell Lung Cancer
Phase: 3Phase III in Spain, 2Phase II, 1Phase I